|
|
|
|
|
by internet_user
499 days ago
|
|
given lack of success with ME/CFS, do you think we'll fare any better this time? post-viral syndromes have been with us for a long time. outside of very clear sequelae like definitive texbook case of autoimmune disease or something obvious like that - we don't really know how to treat them? |
|
we now have novel technology being used like PET scanning, T cell biosensors, and single molecule ultrasensitive assays.
Antigen/superantigen persistence is shared and may be treated with extended courses of antivirals, monoclonal antibodies, immune modulators, and even trying checkpoint inhibitors to reverse T cell exhaustion.
the textbook is being rewritten and a key publication on how to treat at least Long COVID based on what I mentioned above will come out next week. NIH will launch their trials very soon likely announcing in March.